Digital Health Startups

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

1 investor

AMGA is a membership association for medical groups and integrated health systems in the United States, providing conferences, benchmarking surveys, publications, and consulting on topics such as physician-hospital integration, value-based care, and adult immunization. It also runs the AMGA Foundation, which coordinates public health initiatives targeting chronic conditions like diabetes and cardiovascular risk.

1 investor

AMHC is a Certified Community Behavioral Health Clinic providing integrated mental health and substance use treatment, crisis support, sexual assault services, brain injury care, and programs for adults with intellectual disabilities. Serving youth, adults, and families across Aroostook, Hancock, and Washington counties in Maine, it operates 27 service locations as the region's largest behavioral healthcare provider.

1 investor

AMI (Acute Medical Innovation) develops medical device hardware and software-as-a-medical-device (SaMD) to redefine stethoscope-based auscultation, including the Cardio-EGG (AMI-SSS01 series phonocardiography device) that simultaneously captures heart sounds and ECG. Using deep learning and other machine learning models trained on clinical data, it builds diagnostic-assist tools for heart disease and a telemedicine support system called "Cloud Choshin" for sharing heart sound, ECG, and analysis results.

1 investor

Amicare provides a digital workflow for coordinating home care transitions, letting families, hospitals, clinics, and care organizations submit referrals, match compatible home care support, and communicate in real time. The platform is aimed at care coordinators, discharge teams, and home care providers, with a stated focus on Ontario, Canada.

1 investor

AMIRA-Welt is an education and community platform for German pharmacy staff (PTA, PKA, PhiP and pharmacists), offering professional courses via its academy and campus, a magazine, surveys, and a subscription "AMIRA-Box" with OTC product samples to test. Membership is free and aimed at local pharmacy teams; the platform also serves partner brands and manufacturers.

1 investor

AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma. The company translates cancer biomarker research into tests designed to stratify patient risk and optimize treatment allocation.

1 investor

Ampersand Health develops personalised digital therapy apps for people living with long-term inflammatory conditions such as IBD, offering evidence-based courses, symptom tracking, and clinician communication to support self-management and prolong remission. Its content is co-created with researchers, clinicians, and patient groups at London hospitals.

1 investor

Amplifai develops an AI-powered platform (TFscan) that detects diabetic foot complications in real time to support clinical decision-making and prevent amputations. The system integrates with hospital and clinic infrastructure to provide risk scores and analytics for patient care teams.

1 investor

Amplitude VC creates, builds, and grows companies specializing in precision medicine to transform patient outcomes. The firm invests from ideation through patient care, focusing on innovations in human health.

1 investor

Amprion develops and offers SAAmplify-αSYN, a validated diagnostic test that detects misfolded pathological α-synuclein in cerebrospinal fluid to support the diagnosis of neurodegenerative disorders such as Parkinson's, Lewy body dementia, and Alzheimer's. It serves physicians and researchers seeking biological confirmation of neurodegenerative disease.

1 investor

AMPS provides healthcare cost reduction services for self-funded employers, third-party administrators, and payors, offering claim repricing (PriceDynamix), claims editing and medical bill review (ClaimInsight), and pharmacy benefit management (Drexi). The company focuses on reducing healthcare spend while managing member care.

1 investor

Anagin develops targeted therapies for neurological and psychiatric diseases caused by disrupted synaptic plasticity, including PTSD, traumatic brain injury, depression, neuropathic pain, Alzheimer's, and Parkinson's disease.

1 investor

RxList is an online drug information reference that provides details on prescription medications, drug classifications, comparisons, vitamins and supplements. It offers consumer tools such as a drug interaction checker and pill identifier.

1 investor

Anamnèse offers a modular e-health software platform for digitizing care pathways, combining shared calendars, medical records, patient evaluation via 250+ scales/scores, telemedicine, care-pathway management (eParcours), PROM/PREM collection, and clinical research tools. It serves healthcare and prevention actors across France — practitioners, CPTS, MSP, clinics, companies, schools and mutual insurers — from city medicine to hospital and medico-social settings.

1 investor

Andor Health provides AI-powered virtual healthcare communication and collaboration solutions that enable real-time coordination between care teams to improve patient outcomes and reduce clinician burnout. The platform serves healthcare providers, hospitals, and health systems.

1 investor

AnewHealth is a national medication management and pharmacy care provider offering integrated clinical pharmacy services and technology, including its MedWise medication optimization platform and Pharmastar pharmacy benefit management, for patients with complex, chronic care needs and the healthcare providers and payers serving them. Formed in 2023 from ExactCare Pharmacy and Tabula Rasa Healthcare, it is licensed in all 50 U.S. states and Washington, D.C.</parameter> <parameter name="hq_country">US

1 investor

Angel City Bio is a physician-scientist founded pharmaceutical company developing bile-acid-based treatments for gastrointestinal diseases, with programs targeting indications such as GLP-1-associated gallbladder disease and Crohn's disease. Its approach uses enterohepatic recirculation biology and 505(b)(2) regulatory pathways to pursue multiple drug targets.

1 investor

AngelEye Health offers a cloud-based platform for hospital neonatal intensive care units (NICUs) that combines NICU navigation and discharge coordination, feeding management, and secure live-stream video and messaging. It integrates with hospital EHR systems to support care teams and connect families with their hospitalized infants.

1 investor

AngelSense provides a personal GPS tracking and monitoring service designed for the special needs community, helping parents and caregivers locate and safeguard children with special needs. Its customer care team is staffed by special needs parents who use the product with their own children.

1 investor

PCaVision is a diagnostic tool that combines multiparametric ultrasound imaging with AI algorithms to detect suspicious areas for prostate cancer, offering urologists a diagnostic pathway that does not require MRI. It is aimed at urologists, hospitals, and clinics, and is CE/MDR Class IIb certified for use in authorized EU markets.

1 investor

AngioInsight develops AI-powered software for analyzing coronary angiography images to detect coronary microvascular dysfunction and coronary artery disease in cardiology. The platform assists clinicians in evaluating angiographic images for stenosis, physiology, and microvascular function, particularly serving women's heart health.

1 investor

Aniva offers a yearly membership that includes a 100+ biomarker blood test, clinician-reviewed results, biological age calculation, and a personalized action plan covering supplements, nutrition, and lifestyle, all tracked on a dashboard. Aimed at consumers who want proactive health optimization, it operates through partner labs across Germany and provides a personal health concierge.</parameter> <parameter name="founders">[]

1 investor

Anjo is an AI platform that uses data from smart wearables to continuously monitor physiological signals and detect early signs of allergic reactions or anaphylaxis. It provides remote monitoring, alerts, and allergy insights for families and individuals living with life-threatening allergies, and supplies data to physicians for care decisions.

1 investor